Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10817869 | Clinical Biochemistry | 2012 | 4 Pages |
Abstract
⺠Serum PEDF levels are associated with various metabolic disorders. ⺠NAFLD is a hepatic manifestation of the metabolic syndrome as well. ⺠Serum levels of PEDF are independently correlated with P-III-P. ⺠Serum PEDF levels may be a novel marker of liver fibrosis in patients with NAFLD.
Keywords
HDL-CHOMA-IRALTSFAWBCNASFFAFPGHbA1chsCRPPEDFVFAγ-GTPP-III-PNAFLDIRIL/Sγ-glutamyl transpeptidaseASTAspartate aminotransferaseAlanine aminotransferasehomeostasis model assessment of insulin resistanceFree fatty acidinflammationstandard deviationfasting plasma insulinNonalcoholic fatty liver diseaseTriglyceridesELISAEnzyme-linked immunosorbent assaycomputed tomographyDiabetes mellitusPigment epithelium-derived factorHypertensionFibrosisFasting plasma glucoseNAFLD activity scoreHemoglobinGlycated hemoglobinHyperlipidemiahigh-sensitivity C-reactive proteinLivertotal cholesterolHigh-density lipoprotein-cholesterolwhite blood cells
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Hideyuki Hyogo, Sho-ichi Yamagishi, Sayaka Maeda, Yuki Kimura, Tomokazu Ishitobi, Kazuaki Chayama,